FTRE

18.5507.94%
DV

Drayton Virkler

President & Chief Commercial Officer

Mr. Drayton Virkler was President of Commercial at Fortrea Holdings Inc and serves as its President and Chief Commercial Officer. He served as a Senior Director of Investor Relations Department at Talecris Biotherapeutics Holdings Corp. since January 4, 2010. Mr. Virkler is responsible for building and leading Talecris' Investor Relations department, including communications with the analyst and investor communities and all other shareholder communications. Mr. Virkler leverages his expertise in these critical areas to inform investors about Talecris' plasma-derived protein therapies. He has diverse skill set combines knowledge and experience in the areas of pharmaceutical operations, sales and marketing, commercial development and finance. Prior to Talecris, he was employed at GlaxoSmithKline for five years including served as its Senior Product Manager of the Migraine Marketing Team and Product Director of Advair Marketing. Prior to GlaxoSmithKline, he served as a Research and Development Chemist of a Specialty Chemical Manufacturer. Mr. Virkler holds an MBA from Duke University and Bachelor of Science from Washington and Lee University.

Positions